Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -12.77%2.04B | -7.77%452.5M | -25.36%545.76M | -29.03%2.34B | -20.97%527.25M | -28.65%592.93M | -35.41%490.61M | -29.84%731.22M | -24.56%3.3B | -31.41%667.18M |
| Cost of revenue | 1.71%733.6M | -1.77%156.2M | 37.23%225.92M | -44.41%721.26M | -38.56%200.64M | -51.54%196.97M | -20.02%159.02M | -54.98%164.63M | -46.53%1.3B | -44.41%326.58M |
| Gross profit | -19.21%1.31B | -10.64%296.3M | -43.55%319.83M | -19.06%1.62B | -4.11%326.61M | -6.73%395.96M | -40.86%331.59M | -16.26%566.59M | 2.80%2B | -11.59%340.6M |
| Operating expense | -14.95%1.67B | -16.79%421.87M | -23.12%429.16M | -25.96%1.96B | -23.48%431.22M | -28.94%467.17M | -25.17%506.98M | -25.91%558.2M | -7.81%2.65B | -19.12%563.57M |
| Staff costs | -18.47%864.91M | ---- | ---- | -32.00%1.06B | ---- | ---- | ---- | ---- | -4.75%1.56B | ---- |
| Selling and administrative expenses | -14.09%38.46M | ---- | ---- | -36.77%44.76M | ---- | ---- | ---- | ---- | -36.48%70.79M | ---- |
| -Selling and marketing expense | -14.09%38.46M | ---- | ---- | -36.77%44.76M | ---- | ---- | ---- | ---- | -36.48%70.79M | ---- |
| Depreciation and amortization | 416.43%1.82M | ---- | ---- | 1,117.24%353K | ---- | ---- | ---- | ---- | -99.30%29K | ---- |
| -Depreciation | 416.43%1.82M | ---- | ---- | 1,117.24%353K | ---- | ---- | ---- | ---- | -99.30%29K | ---- |
| Rent and land expenses | -1.51%343.29M | ---- | ---- | -18.35%348.56M | ---- | ---- | ---- | ---- | -9.09%426.89M | ---- |
| Other operating expenses | -17.19%421.47M | ---- | ---- | -14.32%508.97M | ---- | ---- | ---- | ---- | -9.09%594.03M | ---- |
| Operating profit | -5.18%-360.56M | 28.40%-125.57M | -1,402.72%-109.32M | 47.22%-342.81M | 53.09%-104.6M | 69.42%-71.21M | -50.10%-175.39M | 110.93%8.39M | 30.07%-649.5M | 28.44%-222.97M |
| Net non-operating interest income (expenses) | -46.16%-25.16M | -24.76%-5.93M | -57.51%-7.42M | -3.76%-17.21M | 14.38%-3.73M | 8.93%-4.02M | -12.92%-4.75M | -30.42%-4.71M | -14.60%-16.59M | -22.72%-4.35M |
| Non-operating interest income | 3,333.33%103K | 750.00%17K | --0 | -91.43%3K | -80.00%1K | --0 | -66.67%2K | --0 | 29.63%35K | -16.67%5K |
| Non-operating interest expense | 46.74%25.26M | 25.07%5.95M | 57.51%7.42M | 3.55%17.22M | -14.45%3.73M | -9.01%4.02M | 12.81%4.76M | 29.70%4.71M | 14.62%16.63M | 22.65%4.36M |
| Net investment income | 18.98%13.38M | -14.18%11.25M | -27.49%5.96M | 0 | -5.08%13.1M | -11.35%8.21M | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 324.25%8.26M | 101.94%1.95M | 0 | -1,242.43%-4.08M | -874.30%-100.3M | -902.51%-100M | ||||
| Less:Other special charges | -980.06%-21.02M | ---- | ---- | -101.94%-1.95M | --0 | --4.08M | ---- | ---- | 17,715.99%100.3M | 41,052.26%100M |
| Less:Write off | --12.76M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 590.22%238.01M | -17.42%8.33M | 3,552.23%210.04M | -96.26%34.48M | -95.04%10.21M | -96.20%8.44M | -96.69%10.09M | -96.96%5.75M | -16.84%921.61M | -24.17%205.67M |
| Income before tax | 59.64%-126.08M | 26.31%-116.98M | 889.44%93.29M | -285.57%-312.35M | 18.76%-92.17M | -362.83%-70.87M | -184.18%-158.73M | -91.31%9.43M | 1.15%168.31M | -155.07%-113.45M |
| Income tax | -65.58%3.19M | -22.84%1.88M | -13.83%2.14M | -8.05%9.27M | -14.70%2.21M | -14.68%2.14M | -2.67%2.44M | 0.20%2.48M | -9.09%10.08M | 3.02%2.59M |
| Net income | 59.81%-129.27M | 26.25%-118.86M | 1,211.96%91.16M | -303.25%-321.62M | 18.67%-94.38M | -309.77%-73.01M | -186.63%-161.17M | -93.45%6.95M | 1.89%158.23M | -146.93%-116.04M |
| Net income continuous operations | 59.81%-129.27M | 26.25%-118.86M | 1,211.97%91.16M | -303.25%-321.62M | 18.67%-94.38M | -309.74%-73.01M | -186.63%-161.17M | -93.45%6.95M | 1.89%158.23M | -146.93%-116.04M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 59.81%-129.27M | 26.25%-118.86M | 1,211.96%91.16M | -303.25%-321.62M | 18.67%-94.38M | -309.77%-73.01M | -186.63%-161.17M | -93.45%6.95M | 1.89%158.23M | -146.93%-116.04M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 59.81%-129.27M | 26.25%-118.86M | 1,211.96%91.16M | -303.25%-321.62M | 18.67%-94.38M | -309.77%-73.01M | -186.63%-161.17M | -93.45%6.95M | 1.89%158.23M | -146.93%-116.04M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 59.81%-54.67 | 26.26%-50.26 | 1,215.70%38.55 | -303.27%-136.03 | 18.66%-39.92 | -309.55%-30.88 | -186.62%-68.16 | -93.47%2.93 | 1.79%66.92 | -146.51%-49.08 |
| Diluted earnings per share | 59.81%-54.67 | 26.25%-50.2767 | 1,215.70%38.55 | -303.88%-136.03 | 18.66%-39.92 | -309.57%-30.8818 | -186.90%-68.1693 | -93.45%2.93 | 1.78%66.72 | -146.51%-49.08 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |